Tag: FDA Draft Guidance

FDA Draft Guidance

FDA Draft Guidance: Potentially a Significant Danger

The Coalition has developed an aggressive plan to address the FDA’s recent “draft guidance” for including risk information in advertising and other marketing materials. Under the leadership of Harry Sweeney, the Coalition has developed an aggressive plan to address the FDA’s recent “draft guidance” for presenting risk information in advertising and other marketing materials.

Read more

FDA Announces New "Draft Guidance"; CHC Solicits Your Participation in Formal Comments

Discuss this issue with other healthcare communication professionals in the Coalition’s LinkedIn Group free work at home jobs May 26, 2009 — FDA released extensive “draft guidance” today on how advertisers must include risk information in drug and device advertising aimed at consumers and professionals. While critics and supporters of drug marketing will find much […]

Read more